Author: Ochsner M. Jaekel K. Mutz M. Anderson G.P. John E.
Publisher: Elsevier
ISSN: 0223-5234
Source: European Journal of Medicinal Chemistry, Vol.34, Iss.6, 1999-06, pp. : 451-462
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phosphodiesterase 4 and tolerance to 2 -adrenoceptor agonists in asthma
Trends in Pharmacological Sciences, Vol. 17, Iss. 9, 1996-09 ,pp. :
Long-acting 2-adrenoceptor agonists: increased risk of death?
Reactions Weekly, Vol. 1, Iss. 1072, 2005-01 ,pp. :
Inhaled 2-Adrenoceptor Agonists: Cardiovascular Safety in Patients with Obstructive Lung Disease
Drugs, Vol. 65, Iss. 12, 2005-01 ,pp. :
Cell type-specific regulation of 2 -adrenoceptor mRNA by agonists
European Journal of Pharmacology, Vol. 331, Iss. 1, 1997-07 ,pp. :